Media Mentions7.18.25
Pharma Startup Executives Must Fight Trimmed SEC Fraud Suit
Paul Kisslinger discusses federal court's dismissal of SEC scheme liability claims
In a recent Bloomberg Law article, partner and Financial and Regulatory Litigation group co-chair Paul Kisslinger commented on a federal court ruling that dismissed SEC scheme liability claims against his client in a digital pharmacy fraud case involving Medly Health Inc.
Keep Up to Date in a Changing World
Do you want to receive more valuable insights directly in your inbox? Visit our subscription center and let us know what you’re interested in learning more about.
